Displaying 831–840 of 865 results
Mar 29, 2013
DHA and EPA for Stargardt Disease — an Evolving Story
These healthy fats have exciting potential for treating a wide range of retinal degenerations and other health conditions.
Mar 22, 2013
What Losing Vision Has Taught Me
Author Shawn Maloney describes his journey with RP.
Mar 15, 2013
Proving a Vision-Saving Treatment Works
The information gleaned from ProgSTAR will be of enormous value in designing future clinical trials for Stargardt disease treatments.
Mar 8, 2013
Staying Alive: Saving Retinal Cells to Preserve Vision
Sometimes, saving vision simply comes down to keeping retinal cells alive, or at least slowing their degeneration.
Feb 18, 2013
More good news about treatments and technological advances for restoring vision for people with retinal diseases.
Feb 14, 2013
How an FDA-Approved Retinal Prosthesis Came To Be
The Argus II Retinal Prosthesis System was recently granted market approval by the U.S. Food and Drug Administration (FDA), which marks a significant milestone in the development of a therapy that has spanned more than 20 years.
Feb 13, 2013
Appreciating the Beauty of the Retina
Even though the best retinal researchers still don’t understand the science completely, everyone can appreciate the basics, including how to keep their retinas as healthy as possible.
Jan 23, 2013
Safely Harnessing the Power of Stem Cells
In the not-too-distant future, researchers will be able to turn stem cells into new photoreceptors for people who have lost vision to a retinal disease. But they must also carefully harness their power to ensure positive consequences.
Jan 15, 2013
Why Face Recognition Can Be Difficult with Central Vision Loss
Diseases such as age-related macular degeneration, cone-rod dystrophy and Stargardt disease cause scotomas, or blind spots, which often have devastating effects on central vision. They cause gaps in a person’s visual field, making it difficult to see words in a book, images on a computer monitor or TV and the features of someone’s face.
Jan 10, 2013
Orphan Drugs Get Special Treatment
For developers of treatments for rare diseases — including inherited retinal conditions — “orphan” status provides valuable benefits, such as tax incentives, access to special research grants and assistance with clinical trial design.